Therapeutic local procedures: pleurodesis Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=311 Year: 2002
Pleural biopsy and talc pleurodesis in undiagnosed recurrent pleural effusions: Many trades which one to choose? Source: International Congress 2016 – Open problems in thoracic surgery Year: 2016
Efficacy of thoracoscopic talc poudrage pleurodesis and predictive factors for its success in malignant pleural effusions Source: Eur Respir J 2005; 26: Suppl. 49, 72s Year: 2005
Audit of success rate and complications of talc slurry pleurodesis for malignant pleural effusions Source: Annual Congress 2008 - Pleural diseases and interventions Year: 2008
Medical thoracoscopy: a safe approach for treatment of pleural empyema. Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction Year: 2021
Malignant pleural effusions Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=177 Year: 2002
Outcomes of the management of malignant pleural effusions with talc poudrage or talc slurry following medical thoracoscopy Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors Year: 2015
Short-term safety of thoracoscopic talc pleurodesis for recurrent primary spontaneous pneumothorax: a prospective European multicentre study Source: Eur Respir J 2011; 38: 770-773 Year: 2011
Diagnostic pleuroscopy and pleuroscopic talc pleurodesis in malignant pleural effusions – a study on efficacy and safety Source: Annual Congress 2009 - Pleural and mediastinal diseases Year: 2009
Pleural techniques for pulmonary physicians Source: Annual Congress 2007 - PG16 - Management of pleural problems in your practice today Year: 2007
Optimal treatment of pleurodesis for malignant pleural effusion in 2017 Source: ERS Skills course - Medical thoracoscopy Year: 2017
Therapeutic local procedures: chest tubes and therapeutic thoracentesis Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=297 Year: 2002
Prognostic factors associated to survival in patients with malignant pleural effusion (MPE) undergoing talc poudrage pleurodesis (TPP) Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016
An examination of the factors for successful pleurodesis against malignant pleural effusion (MPE) Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016
Treatment of parapneumonic pleural effusion and empyema: conservative view Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=199 Year: 2004
Safety and efficacy of pleurodesis with thoracoscopic doxycycline poudrage in malignant pleural effusion Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions Year: 2011
Outpatient management of malignant pleural effusion in patients unfit for pleurodesis Source: International Congress 2016 – Open problems in thoracic surgery Year: 2016
Surgical problems with the malignant pleural space Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis Year: 2006
Talc pleurodesis in malignant pleural effusions: A 5-year experience Source: Annual Congress 2012 - Medical access to the pleura Year: 2012
Advanced techniques in medical thoracoscopy Source: Eur Respir J 2006; 28: 1051-1059 Year: 2006